Targeting protein misfolding in neurodegeneration

Origami Therapeutics CEO on harnessing autophagy to precisely target disease-causing proteins in the brain. Aptly-named US biotech Origami Therapeutics is working to redefine how neurodegenerative diseases are treated, building on the biological insight that many...

Panelist at Bio International Convention 2025

Beth J. Hoffman, PhD, Founder and CEO of Origami Therapeutics, Inc. was a panelist for: Next-Generation Alzheimer’s Disease Therapies As the search for effective treatments for Alzheimer’s disease intensifies, join us for a compelling panel discussion on the...

Warning: Invalid argument supplied for foreach() in /home/origam10/public_html/wp-content/plugins/gdpr-cookie-consent/public/templates/cookie-notice.php on line 84

Warning: Invalid argument supplied for foreach() in /home/origam10/public_html/wp-content/plugins/gdpr-cookie-consent/public/templates/cookie-notice.php on line 89